Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SLC6A12 antisense RNA 1 (SLC6A12-AS1)
- Target
- SLC6A12-AS1
- Molecular classification
- Long non-coding RNA (lncRNA), Antisense RNA, Other
01
Overview
SLC6A12 antisense RNA 1 (SLC6A12-AS1) is a long non-coding RNA (lncRNA) classified as an antisense transcript to the protein-coding gene SLC6A12, which encodes the sodium- and chloride-dependent betaine transporter[4][8]. SLC6A12-AS1 is not a protein-coding gene and does not encode any receptor, transporter, or enzyme. Instead, as an antisense lncRNA, it is presumed—by analogy with numerous characterized antisense RNAs—to possibly regulate the expression of its sense partner gene (SLC6A12), most likely through mechanisms such as influencing mRNA stability, transcriptional regulation, or chromatin modification, though no direct experimental evidence is currently published for SLC6A12-AS1 specifically[3][6]. There are no reports that SLC6A12-AS1 is a direct disease gene, therapeutic target, or biomarker, and no drugs are known to interact with it.
- Other names
- SLC6A12-AS1
02
Biological functions
Regulation of gene expression (via antisense mechanisms)Chromatin modification (putative, based on lncRNA function)Epigenetic regulation (putative)Other
03
Disease associations
Other (no direct disease associations yet reported for SLC6A12-AS1 specifically)
Beyond the preview
Go deeper on SLC6A12 antisense RNA 1 (SLC6A12-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SLC6A12 antisense RNA 1 (SLC6A12-AS1).